Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Urologic Surgery Outcomes
Urologic Surgery ACS NSQIP Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s urologic surgery ACS NSQIP performance benchmarked against 590 participating sites.
| Urologic Surgery (590 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidityᵃ | 459 | 9.80% | 12.61% |
| Cardiac | 459 | 0.87% | 0.88% |
| Pneumoniaᵇ | 458 | 0.22% | 1.15% |
| Unplanned Intubation | 459 | 1.31% | 0.76% |
| Ventilator > 48 Hours | 459 | 1.09% | 0.44% |
| Renal Failureᵃ | 459 | 4.58% | 2.47% |
| Urinary Tract Infection (UTI) | 459 | 1.09% | 2.46% |
| Surgical Site Infection (SSI) | 458 | 4.59% | 5.49% |
| Sepsis | 459 | 2.61% | 3.20% |
| C.diff Colitis | 459 | 1.96% | 0.76% |
| Unplanned Reoperation | 459 | 2.83% | 2.53% |
| Unplanned Readmission | 459 | 12.85% | 10.75% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
ᵇIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
